Brief: Xspray Pharma Completes PopPK Modeling For NDA Submission Of XS003
11/07/2025 13:14
July 11 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST: COMPLETES POPPK MODELING FOR NDA SUBMISSION OF XS003 Source text: ID:nMFN3kg4BP Further company coverage: XSPRAY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003